Harrow, Inc. - 11.875% Senior Notes due 2027

Harrow, Inc. - 11.875% Senior Notes due 2027 Share · US4158583074 · HROWM (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Harrow, Inc. - 11.875% Senior Notes due 2027
No Price
Share Float & Liquidity
Free Float 83,40 %
Shares Float 43,08 M
Shares Outstanding 51,65 M
Company Profile for Harrow, Inc. - 11.875% Senior Notes due 2027 Share
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Company Data

Name Harrow, Inc. - 11.875% Senior Notes due 2027
Company Harrow Health, Inc. 11.875% Senior Notes due 2027
Symbol HROWM
Website http://www.harrowinc.com
Primary Exchange XNAS NASDAQ
ISIN US4158583074
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mark L. Baum
Market Capitalization 1 Mrd.
Country United States of America
Currency USD
Employees 0,2 T
Address , Nashville
IPO Date 2022-12-29
Dividends from 'Harrow, Inc. - 11.875% Senior Notes due 2027'
Ex-Date Dividend per Share
15.07.2025 0,74 USD
15.04.2025 0,74 USD
15.01.2025 0,74 USD
15.10.2024 0,74 USD
15.07.2024 0,74 USD
12.04.2024 0,74 USD
11.01.2024 0,74 USD
12.10.2023 0,74 USD
13.07.2023 0,74 USD
13.04.2023 0,74 USD

Ticker Symbols

Name Symbol
NASDAQ HROWM
More Shares
Investors who hold Harrow, Inc. - 11.875% Senior Notes due 2027 also have the following shares in their portfolio:
3 GORGES FIN 19/49
3 GORGES FIN 19/49 Bond
SW.PAC.MTN F 20/30 MTN
SW.PAC.MTN F 20/30 MTN Bond